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Abstract: Biofilm formation by Staphylococcus aureus represents a problem in both the 
medical field and the food industry, because the biofilm structure provides protection to 
embedded cells and it strongly attaches to surfaces. This circumstance is leading to many 
research programs seeking new alternatives to control biofilm formation by this pathogen. 
In this study we show that a potent inhibition of biofilm mass production can be achieved 
in community-associated methicillin-resistant S. aureus (CA-MRSA) and methicillin-sensitive 
strains using plant compounds, such as individual constituents (ICs) of essential oils 
(carvacrol, citral, and (+)-limonene). The Crystal Violet staining technique was used to 
evaluate biofilm mass formation during 40 h of incubation. Carvacrol is the most effective 
IC, abrogating biofilm formation in all strains tested, while CA-MRSA was the most 
sensitive phenotype to any of the ICs tested. Inhibition of planktonic cells by ICs during 
initial growth stages could partially explain the inhibition of biofilm formation. Overall, 
our results show the potential of EOs to prevent biofilm formation, especially in strains 
that exhibit resistance to other antimicrobials. As these compounds are food additives 
generally recognized as safe, their anti-biofilm properties may lead to important new 
applications, such as sanitizers, in the food industry or in clinical settings. 
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1. Introduction 
Microbial communities adhered to surfaces are commonly referred as biofilms and are well recognized 
to cause hard-to-treat bacterial infections, being associated with around 65% of all human bacterial 
infections worldwide and with 80% of persistent infections in the United States [1–3]. The human 
pathogen Staphylococcus aureus shows a great ability to form biofilms, which represent a serious threat 
to the food industry and clinical settings [4]. S. aureus is well adapted to human colonization because it 
is part of the normal microbiota of the nasopharynx and skin, however, S. aureus penetrates to the 
internal parts of the body during surgical practice or food consumption and causes severe infections 
that can progress to life-threatening diseases, like necrotizing fasciitis, endocarditis, or pneumonia [4]. 
In S. aureus biofilms, cells are embedded in a self-produced extracellular matrix that protects cells not 
only from the host’s immune response but also from any antimicrobial treatment [5]. 
Bacterial biofilms are particularly challenging in the food industry because bacteria contaminate food 
surfaces (e.g., produce or animal carcasses) or food-contact surfaces (e.g., equipment and processing 
environment), and once biofilm is formed, its eradication becomes difficult because it exhibits great 
resilience to environmental stresses, disinfectants, and antimicrobial treatments [6]. As a consequence, 
these biofilms can act as reservoirs of persistent contaminations, cross-contaminations, and post-processing 
contaminations, leading to food spoilage with a potential risk to public health [2,7]. Several factors can 
account for the contamination of food products with S. aureus that often occurs during handling and 
packaging in food industries, including its frequent occurrence on food contact surfaces and the ability 
of some strains to form biofilms in food equipment and environments [8], and its common presence as 
a commensal colonizer of the skin and mucous membranes of healthy animals and humans [3,7]. 
Prevention of biofilm formation is considered preferable to its removal, since the latter is a very 
difficult and demanding task, which can cause recontamination problems due to release of bacterial 
cells and toxins after disruption of the biofilms [9]. Thus, prevention of biofilm formation of S. aureus 
in food and clinical environments is required in order to minimize the potential risk of a widespread 
dissemination of these new multi-drug resistant strains [7,10]. Control measures mostly rely on the 
application of effective cleaning and disinfecting procedures [11,12]. Over the last years, the proven 
antimicrobial efficacy of plant-derived essential oils (EOs) and their individual constituents (ICs) [13] 
has elicited their proposal as a “green alternative” to the routinely used disinfecting products such as 
sodium hypochlorite or quaternary ammonium compounds [14]. Many EOs and ICs are incorporated 
in disinfectant compositions and proposed as novel food preservatives [15] mainly due to their strong 
activity in the inhibition and inactivation of bacteria and fungi. However, more research is needed in 
order to have a better approach to develop the potential use of EOs and ICs as inhibitors of the biofilm 
formation by S. aureus in food and clinical environments. For example, inhibition of biofilm formation 
by these compounds is usually evaluated after 24 h of treatment [16,17], without considering that biofilm 
formation is a dynamic and cyclical process involving attachment, maturation and a final dispersal 
phase [18]. Due to strong bacteriostatic and bactericidal activity shown by the ICs (+)-limonene, citral, 
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and carvacrol against planktonic cells, such as S. aureus, Listeria monocytogenes, Escherichia coli, 
Enterococcus faecium, Salmonella enterica, or Pseudomonas aeruginosa [19–21], we selected these 
ICs to evaluate their potential as inhibitors of biofilm mass production by S. aureus strains. In order to 
cover different types of strains, two community-associated methicillin-resistant S. aureus (CA-MRSA) 
strains (SC-01 and USA300) and two methicillin-sensitive S. aureus (MSSA) strains (Newman and 
UAMS-1) were chosen. The main objective of this work was to study the effect of different concentrations 
of carvacrol, citral, or (+)-limonene on the ability of clinical isolates of S. aureus to form biofilms  
in vitro. Additionally, the effects of these compounds on planktonic cells and their implication in the 
inhibition of biofilm mass production were studied. 
2. Results and Discussion 
2.1. Selection of Effective Compounds According to Their MICs 
The potential activity of ICs as inhibitors of biofilm mass production was firstly addressed by 
determining the MIC of each compound in S. aureus planktonic cells (Table 1). Interestingly, MICs of 
ICs were similar against all S. aureus strains. Thus, (+)-limonene showed a MIC of 5000 µL/L against 
all bacterial strains assayed. For all the strains, the MICs for carvacrol and citral were lower than for 
(+)-limonene (200 and 500 µL/L, respectively). Therefore, non-inhibitory concentrations (NICs) were 
determined at 100, 200, and 2000 µL/L for carvacrol, citral, and (+)-limonene, respectively, against all 
strains tested. 
Table 1. MICs of ICs against S. aureus strains. Minimum inhibitory concentrations  
(MICs) in µL/L of individual constituents (carvacrol, citral, or (+)-limonene) against 
Staphylococcus aureus strains (SC-01, USA300, UAMS-1, and Newman). The non-inhibitory 
concentration (NIC) is shown in parentheses. 
 SC-01 USA300 UAMS-1 Newman 
Carvacrol 200 (100) 200 (100) 200 (100) 200 (100) 
Citral 500 (200) 500 (200) 500 (200) 500 (200) 
(+)-Limonene 5000 (2000) 5000 (2000) 5000 (2000) 5000 (2000) 
2.2. Biofilm Development throughout Time of S. aureus Strains in the Absence and the Presence of ICs 
As a preliminary step to evaluate activity of antimicrobial compounds against biofilm formation, we 
quantified biofilm mass production by all strains. Thus, the biofilm mass was measured during 40 h of 
incubation (Figure 1). 
Using this approach, the patterns of biofilm formation and biofilm thickness were evaluated for each 
strain at every time point. These patterns were characterized by the alternation of the assembly-dissasembly 
of the biofilm. CA-MRSA strain, SC-01 formed the thickest biofilm as measured at any growth time 
from 16 h onwards, reaching a biofilm mass corresponding to 8 absorbance units (AU) after 40 h 
(Figure 1A). 
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Figure 1. Inhibition of biofilm mass production in presence of NIC of carvacrol, citral and 
(+)-limonene. Biofilm development (expressed as optical absorbance units at 595 nm) at  
37 °C of Staphylococcus aureus SC-01 (A); USA300 (B); UAMS-1 (C); or Newman (D) in 
the absence of antimicrobial compounds (●) or in the presence of the non-inhibitory 
concentration (NIC) of each compound: 100 µL/L of carvacrol (●), 200 µL/L of citral (●), 
or 2000 µL/L of (+)-limonene (●). 
Besides, it presented a different growth pattern from the other three strains, since it continued 
increasing its biofilm mass throughout the whole experiment. In contrast, the biofilms formed by 
UAMS-1 (MSSA) and USA300 (CA-MRSA) increased throughout the first 8 h of incubation (over  
4 AU) and then biofilm mass decreased (Figure 1B,C). Moreover, Newman strain (MSSA) presented 
the weakest biofilm forming ability: a growth plateau or declining phase started after peaking at 8 h, 
and the measured absorbance values remained under 3 AU (Figure 1D). 
The effect of the addition of the NIC of each IC on the biofilm development was evaluated by the 
representation of the absorbance values throughout time (Figure 1). The most prominent effect observed 
was the decrease in the biofilm mass after 8 h of incubation in the presence of all ICs tested, which 
corresponded to the peak time point of biofilm mass production in the Newman and UAMS-1 strains 
(MSSA), and the USA300 strain (CA-MRSA). In addition to this, we detected an important reduction in 
the production of biofilm mass in S. aureus SC-01 after 8 h onwards of incubation time in the presence 
of any of the ICs in the growth medium (Figure 1A) (p < 0.05). S. aureus Newman was the least 
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susceptible strain to the action of the ICs, since their addition seemed to cause a delay in the biofilm 
development rather than a reduction in the biofilm mass (Figure 1D). Yet, Newman strain formed 
weak biofilms in all conditions tested, which prevented us from characterizing with precision the 
efficiency of the ICs inhibiting biofilm formation in this particular strain. 
Although we detected similar anti-biofilm activity of the three ICs at their respective NICs, 
carvacrol was active at a lower concentration. Carvacrol decreases the biofilm mass production of 
USA300 and UAMS-1 at every time point tested (Figure 1B,C). This contrasted to the anti-biofilm 
activity of the rest ICs, which showed an inhibitory effect that was dependable of the incubation period. 
For instance, the addition of 2000 µL/L of (+)-limonene reduced the production of biofilm mass in  
S. aureus USA300 by 90% after 8 h of incubation, but increased it by 30% after 40 h of incubation 
(Figure 1B). As a consequence, to compare the effect of each IC on S. aureus strains in relation to the 
differences in biofilm development between strains and throughout time, we evaluated the decrease in 
the total biofilm mass production (expressed as the cumulative absorbance thickness measured over 40 h 
of incubation period) for each strain when adding each IC in comparison with the control (Table 2). 
Table 2. Global inhibitory effect of ICs in biofilm formation by S. aureus. Percentage of 
decrease in the cumulative absorbance values in the presence of non-inhibitory concentration 
(NIC) of carvacrol, citral, or (+)-limonene against Staphylococcus aureus strains (SC-01, 
USA300, UAMS-1, and Newman), in comparison to each value in the absence of added 
compounds (control). Cumulative absorbance values indicating the biofilm thickness were 
measured throughout time for a total of 40 h. Values were obtained from the measurement of 
the area under the curve (AUC) and are expressed in optical absorbance units (at 595 nm)·h 
(mean ± standard deviation). Asterisks indicate statistically significant differences between 
each mean AUC value in the presence of each compound with that of the AUC value in  
its absence. Different superscript letters indicate statistically significant differences in the 
percentage of decrease in the AUC value among strains for the same compound. Different 
superscript numbers indicate statistically significant differences in the AUC values among 
compounds for the same strain. ANOVA tests with Bonferroni’s multiple comparison  
Post-tests were used (α = 0.05). 
 SC-01 USA300 UAMS-1 Newman 
Carvacrol 81.51 *,a1 ± 11.16 74.62 *,a1 ± 12.23 74.66 *,a1 ± 2.79 33.28 *,b1 ± 17.34 
Citral 65.00 *,a1 ± 15.30 47.34 *,a1,2 ± 21.50 57.10 *,a2 ± 6.75 0.21 b1 ± 29.78 
(+)-Limonene 77.77 *,a1 ± 6.06 28.54 b2 ± 19.45 26.46 b2 ± 11.83 11.19 b1 ± 9.42 
Thus, Table 2 shows that SC-01 was the most sensitive strain to any IC, decreasing its total biofilm 
mass production to at least 65%; and that Newman experienced a significantly lower reduction in its 
biofilm production when compared to the other strains, regardless of the added compound (p < 0.05). 
Carvacrol was the most effective IC regardless of the tested strain, decreasing more than 30% of 
biofilm mass production to all strains tested (Table 2) and being statistically more effective than  
(+)-limonene (p < 0.05). 
Next, we further evaluated the potential of ICs at lower concentrations to inhibit biofilm mass 
production in the SC-01 strain (CA-MRSA). Figure 2 was obtained by evaluating the evolution of the 
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biofilm mass of SC-01 in the presence of 0.1-fold NIC of each IC. These conditions evidenced  
a reduction in the biofilm mass by approximately 40%, 55%, and 80% after 40 h of incubation using 
ICs concentrations as low as 10, 20, or 200 µL/L of carvacrol, citral, and (+)-limonene, respectively. 
 
Figure 2. Inhibition of biofilm mass production by S. aureus SC-01 in presence of  
0.1× NIC of carvacrol, citral and (+)-limonene. Biofilm development (expressed as optical 
absorbance units at 595 nm) at 37 °C of Staphylococcus aureus SC-01 in the absence of 
antimicrobial compounds (continuous line) or in the presence of 1/10 the non-inhibitory 
concentration (NIC) of each compound: 10 µL/L of carvacrol (●), 20 µL/L of citral (●), or 
200 µL/L of (+)-limonene (●). 
2.3. Effect of ICs on Planktonic Cells in Relation to Biofilm Formation 
The effect of the NIC of ICs on Newman strain would be consistent with a delay in the development 
of the biofilm formation, differing from the effect of the inhibition of biofilm formation that we 
observed in SC-01 strain (Figure 1A,D). Based on these results, we hypothesized that ICs could affect 
the viability of planktonic cells, which may alter the regular cycle of biofilm formation and would 
explain the differences in the biofilm mass that were observed in the absence and the presence of ICs. 
This antimicrobial effect of ICs is probably due to the coexistence of bacterial cells exhibiting 
different physiologies and thus showing different sensitivities to the action of our compounds. In order 
to evaluate the correlation between the effect of ICs on planktonic cells and the biofilm development, 
the planktonic cell concentration of S. aureus Newman was measured during early stages of biofilm 
formation. As shown in Figure 3, the concentration of planktonic cells increased from 107 to 108 CFU/mL 
after the first 8 h of incubation in the absence of antimicrobials. However, in the presence of the NIC 
of any IC the initial concentration of planktonic cells decreased about 1.5 log10 cycles. Similar results 
were obtained for the other strains (data not shown). 
2.4. Discussion 
Natural compounds with antimicrobial and anti-biofilm activity are being promoted for different 
purposes, such as food preservatives, disinfectants and chemotherapeutic agents to replace traditionally 
used chemical agents and antibiotics [22,23]. In addition, exposure to sub-MIC concentrations of  
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some traditional antibiotics and disinfectants can act as an environmental signal triggering biofilm 
formation [24,25], supporting the research on new antimicrobial compounds. MIC values for ICs 
against S. aureus strains showed in this investigation (Table 1) were in agreement with previous 
studies showing the strong inhibitory activity of carvacrol, citral, and (+)-limonene against several 
strains of S. aureus and other bacterial species [21,26,27]. 
 
Figure 3. Inactivation of planktonic cells at sub-MIC values of carvacrol, citral, and  
(+)-limonene. Log10 concentration of planktonic cells (CFU/mL) of Staphylococcus aureus 
Newman when grown at 37 °C on polystyrene surfaces in growth medium without added 
antimicrobial compounds (●), or in the presence of the non-inhibitory concentration (NIC) 
of each compound: 100 µL/L of carvacrol (●), 200 µL/L of citral (●), or 2000 µL/L of  
(+)-limonene (●). 
The study of the evolution of the biofilm mass production revealed that highly diverse patterns of 
adhesion and biofilm formation exist among the different assayed S. aureus strains (Figure 1). We 
found no correlation between each strain’s ability to form a biofilm and its original source of isolation 
and its susceptibility to methicillin. Yet, we detected that biofilm mass production is directly related to 
the incubation time interval, which varies from strain to strain. Therefore, incubation time should be 
considered when comparing biofilm formation ability among strains. For instance, the strains SC-01 
and Newman exhibited increasing and decreasing biofilm thickness over 40 h of incubation period 
(Figure 1A,D). Thus, after 24 h of incubation, which is the usual time to evaluate antimicrobial  
activity of EOs [16,17,26,28], UAMS-1 was a better biofilm forming strain than USA300 and 
Newman (Figure 1). However, after 32 h of incubation, USA300 strain showed a thicker biofilm than 
Newman and UAMS-1 strains which is consistent with what has been previously reported [3,29,30]. 
Addition of NIC of ICs to growth medium inhibited biofilm mass production by S. aureus strains. 
Although most studies agree about the inhibitory effect of EOs and ICs on the biofilm formation [31–39], 
different authors have detected an enhancement of the biofilm production by these compounds under 
some conditions [40–42]. As described for biofilm formation in absence of ICs, the inhibitory effect of 
these compounds on biofilm mass production varied as a function of the time point tested. The biofilm 
formation is a dynamic and cyclical process that involves two initial steps; an initial attachment and  
a subsequent maturation phase. A final dispersal phase occurs when the biofilm reaches a nutrient-deprived 
critical mass or as a response to changing environmental conditions, which causes the detachment of 
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bacteria from the outermost layers of the biofilm and become planktonic single individuals [2,18]. 
Therefore, dependence of the incubation period in the inhibition of biofilm mass production could be 
attributable to a possible delay in the cycles of biofilm assembly-disassembly caused by antimicrobial 
effect of ICs, emphasizing the importance of measuring the anti-biofilm properties of any compound 
of interest at different time points during the process of biofilm formation. Although the representation 
of the stages of biofilm development has been applied to the identification of particularities in mutants 
or the differentiation of strains [43,44], to the best of our knowledge, most studies describing the effect 
of EOs or ICs on the biofilm development only compare the biofilm produced after a certain period of 
incubation, usually 24 h [16,17,26,28]. Comparison of the area under the curve of biofilm for biofilm 
mass production in absence or presence of ICs (Table 2) provided us with a useful parameter to describe 
inhibitory properties of these compounds in biofilm formation. This parameter revealed carvacrol as  
a potent inhibitor of biofilm mass production by all S. aureus strains tested. 
Although resistance to ICs (MIC values) was similar for the planktonic cells of all the strains (Table 1), 
inhibition of biofilm mass production varied as a function of the assayed S. aureus strain (Figure 1). 
This differential behaviour could indicate that different or specific mechanisms of biofilm inhibition 
(other than those related to the delay in the initial attachment) are present depending on the S. aureus 
strain and on the antimicrobial compound. Difference between the planktonic cell concentration of  
S. aureus Newman in the absence and in the presence of the NICs of the ICs after 8 h of incubation 
(Figure 3) could account for the difference observed in the biofilm production at this time point 
(Figure 1D) by delaying the initial attachment and consequently the biofilm mass production. In this 
regard, it is known that the first step of the biofilm development (the initial bacterial adhesion to the 
surface) is conditioned by the growth stage of the bacterial cells [11]. On the other hand, high cell 
density triggers quorum sensing response, based on cell-to-cell communication that regulates genes 
involved in biofilm maturation and maintenance [2,23]. Quorum sensing response is activated when 
the concentration of autoinducers (small molecules secreted by bacteria) exceeds a requisite threshold. 
Therefore, lower initial bacterial counts would delay biofilm mass production [9]. Moreover, these ICs 
can damage cell envelopes [20,21] which could result in a diminished ability to attach to the surface 
and form biofilms, as previously suggested by Kerekes et al. [17]. Likewise, inhibitory effects of ICs 
on planktonic cells could also explain the delay in biofilm formation by the other S. aureus strains. 
However, while biofilm formation by S. aureus Newman in presence of citral and (+)-limonene was 
only delayed, growth of the other strains in presence of ICs also reduced the highest biofilm mass 
(Table 2). Therefore, in contrast to the results obtained with Newman strain, the effect of ICs on 
inhibiting biofilm formation by SC-01, USA300 and UAMS-1 strains would not only be due to the 
inhibitory effect of ICs on planktonic cells, indicating a different mechanism of action by ICs for these 
strains and Newman strain. 
The control of S. aureus in clinical settings has been traditionally performed by increasing 
concentrations of conventional antibiotics, such as β-lactams or glycopeptides. Unfortunately, the 
uncontrolled use of penicillins, like methicillin, to treat patients and livestock contributed in emergence 
of MRSA [45]. MRSA infections show a mortality rate of 20%, and are the leading cause of death by  
a single infectious agent in the USA, high above HIV [46]. In addition to this, a subset of CA-MRSA 
strains has emerged, which are no longer restricted to patients from hospitals or immuno-compromised 
high-risk citizens but in fact have the ability to cause severe and pandemic infections in healthy 
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individuals [47]. The reduced number of effective antimicrobial treatments that are available to eradicate 
multi-drug resistant pathogenic bacteria could lead to recurrent microbial contaminations in food 
industry, and to hard-to-treat infections frequently related to hospitals. In food processing, EOs and 
ICs are of special interest since their natural origin meets consumers’ current reluctance towards 
chemically-synthesized antimicrobials [48]. In addition to their use as sanitizers and disinfectants  
of food equipment and environments, food packaging materials containing antimicrobial compounds 
have gained practical importance in the control of surface contamination [49]. 
The potential of sub-MIC concentrations of carvacrol, citral, and (+)-limonene as inhibitors of the 
biofilm formation in multi-drug resistant strains, such as the CA-MRSA strain SC-01 (Figure 2), 
whose biofilms can develop in the presence of many conventional antibiotics [50], should be further 
considered as anti-biofilm compounds. Finally, another important reason that supports the use of ICs in 
food and clinical environments is the evidence that, unlike conventional antibiotics, these compounds 
would effectively kill bacteria while applying a less selective pressure for the development of 
resistance [51]. 
3. Experimental Section 
3.1. Microorganisms and Growth Conditions 
The four bacterial strains of S. aureus used in this study (Newman, UAMS-1, USA300, and SC-01) 
were obtained from the Kolter laboratory (Harvard Medical School, Boston, MA, USA). Newman 
strain is an antibiotic sensitive (MSSA, from methicillin-sensitive S. aureus) isolate from an 
osteomyelitis patient (Royal South Wants Hospital, Southampton, UK) [52]; UAMS-1 is another MSSA 
osteomyelitis isolate from the University of Arkansas Medical School (Little Rock, AR, USA) [53]; 
USA300 is a CA-MRSA outbreak strain (USA) [45]; and SC-01 is a CA-MRSA isolate from a war 
veteran’s hip wound (Sepulveda Veterans Administration Medical Center, Sepulveda, CA, USA) [54]. 
All of them were clinical isolates, USA300 strain being a major source of community-associated 
outbreaks of S. aureus in America and Europe [55]. 
During this investigation, the strains were kept frozen at −80 °C in cryovials. Broth subcultures 
were prepared by inoculating, with one single colony from a plate, a test tube containing 5 mL of 
sterile Tryptic Soy Broth (TSB) (Biolife, Milan, Italy). After inoculation, the tubes were incubated 
overnight at 37 °C in aerobic conditions (Selecta, mod Incudigit, Barcelona, Spain) to obtain bacterial 
subcultures. With these subcultures, tubes containing 5 mL of TSB were inoculated to a final 
concentration of 107 CFU/mL. These bacterial cultures were incubated under agitation (130 rpm; 
Selecta, mod. Rotabit) at 37 °C for 12 ± 2 h so that the stationary growth phase was reached. 
3.2. Procedure for Biofilm Formation 
For S. aureus biofilm formation, 0.01 mL of a bacterial culture and 0.5 mL of the growth  
medium were inoculated in selected wells in polystyrene 24-well plates (Nunclon Delta Surface, 
Thermo Fisher Scientific, Roskilde, Denmark), attaining an initial concentration of 107 CFU/mL.  
The growth medium was composed by TSB + Glucose 0.5% (VWR, Leuven, Belgium) + NaCl 3% 
(Panreac, Barcelona, Spain). The plates were incubated inside individual plastic bags at 37 °C in static 
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conditions for different incubation times. Biofilms formed by S. aureus were stained with crystal violet 
(0.1%) (Panreac) for better visualization and quantification of the biomass according to O’Toole and 
Kolter [56]. Briefly, the supernatant containing the planktonic cells was extracted from each well, and 
the plates were rinsed with distilled water to remove non-attached cells and left to air-dry for about  
2 h. Next, each well was filled with 300 µL/L of crystal violet solution and incubated at room 
temperature (20–25 °C) for 30 min. The crystal violet solution was removed, and the wells were 
further washed with distilled water. To quantify biofilm formation the crystal violet stain was 
solubilized in 33% acetic acid (Panreac) [57] and absorbance measured at 595 nm using a microplate 
reader (Genios, Tecan, Männedorf, Switzerland). This technique measures total biomass (cells and 
extracellular matrix) [58], and therefore is suitable to determine biofilm removal or inhibition. 
3.3. Determination of Minimum Inhibitory Concentration (MIC) and Quantification of the Effect of 
Sub-MIC Concentrations of EOs and ICs 
For the determination of the MIC of planktonic cells 24-well plates were prepared as previously 
described. Growth medium had been previously added with 10, 50, 100, 200, 500, 1000, 2000, 5000, 
or 10,000 µL/L of carvacrol (PubChem CID: 10364), citral (PubChem CID: 638011; mixture of two 
isomers: geranial and neral), or (+)-limonene (PubChem CID: 440917), and plates were incubated at 
37 °C for 24 h. Carvacrol (≥98%), citral (95%), and (+)-limonene (97%) were purchased from Sigma 
Aldrich (Sigma-Aldrich Chemie, Steinheim, Germany). Positive controls (with bacterial culture but  
no compounds added) and negative controls (with compounds but no bacterial culture added) were 
also included. MIC was noted as the lowest compound concentration at which the optical absorbance 
at 595 nm of the content of each well was equal or lower than that of their negative controls, and the 
non-inhibitory concentration (NIC) was determined as its immediately lower concentration. 
The same procedure for different incubation times was followed for the biofilm formation assay 
throughout time in the presence of 1- or 0.1-fold NIC of carvacrol, citral, or (+)-limonene. Positive 
controls (with bacterial culture but no compounds added) and negative controls (with compounds  
but no bacterial culture added) were also included. The assays were performed in duplicate in three 
independent experiments. 
3.4. Quantification of Planktonic Cells in Biofilm-Growing Cultures 
The supernatant obtained from each well was homogenized (Genios 3, Ika, Königswinter, Germany) 
and adequately diluted in 0.1% (w/v) peptone water (Biolife, Milan, Italy). Next, 0.02-mL aliquots of 
each sample were inoculated in plates containing TSA (Biolife) using the spread plate technique. 
Plates were incubated at 37 °C for 24 h before bacterial counts (CFU/mL). The assays were performed 
in duplicate in three independent experiments. 
3.5. Data Analyses 
All the analyses were performed with PRISM software (GraphPad Software, Inc., San Diego, CA, 
USA). ANOVA tests with Bonferroni’s multiple comparison Post-test were performed to test statistically 
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significant differences among several groups (α = 0.05). The error bars in the figures indicate the  
mean ± standard deviations from the obtained data. 
PRISM software was also used to obtain the measurement of the cumulative absorbance values for 
each strain and compound throughout the total incubation time (40 h). These cumulative absorbance 
values were computed as the area under the curve (AUC) [59] following the trapezoid rule, where the 
total area is the sum of all rectangular trapezoids, each defined by two adjacent absorbance values with 
respect to the ground (in the y axis) and the time between those measurements (in the x axis). Therefore, 
the formula used was: 
AUC =෍ xi·(yi+yi+1)
2
n-1
i = 1
 (1)
with xi denoting the time between measurements, yi denoting the absorbance value for each 
measurement, and n being the total number of measurements. The AUC values were determined for 
each individual experiment as a mean of the two replicates performed per experiment. 
The AUC values were used to express the percentages of decrease in the cumulative absorbance 
values caused by the incorporation of each compound in the growth medium. For each strain and 
compound, the percentage of decrease was calculated for each individual experiment using the formula: 
Percentage of decrease =
AUCcontrol − AUCcompound
AUCcontrol
× 100 (2)
where AUCcontrol and AUCcompound were the cumulative absorbance values in the absence of added 
compounds or in the presence of each one of them, respectively. The mean and standard deviation of 
three individual experiments were also calculated using PRISM software. 
4. Conclusions 
In brief, we have shown the importance of studying the evolution of the biofilm development 
throughout time when describing the effect of ICs on the biofilm formation by each bacterial strain. 
Due to the cyclic behavior inherent to the biofilm development, the measured biofilm mass fluctuates 
in response to the disassembly and reforming on the biofilm. The four clinical S. aureus strains showed 
different patterns of biofilm development, and also exhibited different sensitivity to the ICs carvacrol, 
citral, and (+)-limonene. Overall, the three ICs acted similarly, although analysis of the cumulative 
biofilm production highlighted carvacrol as the best inhibitor of biofilm mass production, decreasing 
more than 40% of biofilm mass production for any strain. Interestingly, our ICs were capable of 
reducing biofilm mass of SC-01 strain in 65%–85% when incorporating the NIC of any IC (100, 200, 
and 2000 µL/L of carvacrol, citral, and (+)-limonene, respectively) in the growth medium (after 16 h 
of incubation). These compounds also inhibited biofilm mass production by SC-01 at concentrations 
10 times lower than the NIC. This is particularly important in CA-MRSA strains, which are able to 
grow and form biofilm in the presence of many different conventional antibiotics. 
The mechanism(s) by which ICs modify S. aureus’ pattern of biofilm development are still 
unknown. The absence or delay in the first peak of the biofilm development in presence of ICs,  
along with the initial partial inactivation of planktonic cells in the strain Newman, suggested that the 
Molecules 2015, 20 11368 
 
 
delay in the attachment of cells would probably be one of the factors implied in the effectiveness of the 
tested ICs. 
The anti-biofilm properties of our molecules suggest that they may have a great potential to fight 
against bacterial biofilms in the food industry. Furthermore, ICs could be used to treat biofilm-associated 
infections caused by multi-drug resistant pathogenic bacteria. 
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